Bridget A Martell's Net Worth
$0
Who is Bridget A Martell?
Bridget A Martell does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ACHIEVE LIFE SCIENCES, INC., Kura Oncology, Inc., Aligos Therapeutics, Inc., COLUMBIA LABORATORIES INC, POINT Biopharma Global Inc., Old Ayala, Inc, Ayala Pharmaceuticals, Inc., and DELCATH SYSTEMS, INC..
SEC CIK
Bridget A Martell's CIK is 0001629627
Past Insider Trading and Trends
2024 was Bridget A Martell's most active year for acquiring shares with 4 total transactions. Bridget A Martell's most active month to acquire stocks was the month of January. 2024 was Bridget A Martell's most active year for disposing of shares, totalling 1 transactions. Bridget A Martell's most active month to dispose stocks was the month of January. 2023 saw Bridget A Martell paying a total of $0.00 for 132,003 shares, this is the most they've acquired in one year. In 2024 Bridget A Martell cashed out on 30,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACHIEVE LIFE SCIENCES, INC. (ACHV) Snapshot price: $4.165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kura Oncology, Inc. (KURA) Snapshot price: $19.29
Acting Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COLUMBIA LABORATORIES INC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 15.5K |
—
|
—
| 15.5K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
POINT Biopharma Global Inc. (PNT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||